Terminated NA INTERVENTIONAL 1-arm NCT05034848

Peripheral Artery Disease (PAD) : Its Effects on Bone (AMICOS)

Sponsor: Centre Hospitalier Régional d'Orléans

Conditions Bone Peripheral Artery Disease

Interventions Assessment of BMD by DXA and HRpQCT

Updated 5 times since 2021 Last updated: Dec 27, 2022 Started: Mar 31, 2021 Primary completion: May 19, 2021 Completion: May 19, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

no practitionner

Other terminated trials from Centre Hospitalier Régional d'Orléans

See all terminations from Centre Hospitalier Régional d'Orléans

Other Bone trials with similar outcome

Browse all Bone trials

Listed as NCT05034848, this NA trial focuses on Bone and Peripheral Artery Disease and remains terminated or withdrawn. Sponsored by Centre Hospitalier Régional d'Orléans, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Terminated NA
Sep 2024 — Sep 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Feb 2023 — Jul 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Oct 2021 — Feb 2023 [monthly]

Recruiting NA

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Régional d'Orléans

Data source: Centre Hospitalier Régional d'Orléans

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Orléans, France